TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $145 | -99.9% | 97,000 | 0.0% | 0.23% | +10.1% |
| Q3 2022 | $162,000 | -19.0% | 97,000 | -3.0% | 0.21% | -12.2% |
| Q2 2022 | $200,000 | +13.6% | 100,000 | +49.3% | 0.24% | -14.7% |
| Q1 2022 | $176,000 | -12.4% | 67,000 | -7.6% | 0.28% | +7.3% |
| Q4 2021 | $201,000 | -60.2% | 72,509 | -44.4% | 0.26% | -61.9% |
| Q3 2021 | $505,000 | +94.2% | 130,500 | +226.2% | 0.68% | +89.9% |
| Q2 2021 | $260,000 | +116.7% | 40,000 | +291.3% | 0.36% | +76.4% |
| Q4 2020 | $120,000 | -57.6% | 10,223 | -81.3% | 0.20% | -67.0% |
| Q3 2020 | $283,000 | +15.0% | 54,723 | -56.4% | 0.62% | -7.9% |
| Q2 2020 | $246,000 | +121.6% | 125,401 | +88.9% | 0.67% | +72.2% |
| Q1 2020 | $111,000 | -30.2% | 66,400 | -2.2% | 0.39% | -26.8% |
| Q4 2019 | $159,000 | – | 67,900 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,125,322 | $8,251,000 | 3.72% |
| Ikarian Capital, LLC | 2,788,853 | $5,577,000 | 1.02% |
| Telemetry Investments, L.L.C. | 100,000 | $200,000 | 0.24% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $57,000 | 0.08% |
| JOHNSON & JOHNSON | 84,003 | $168,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $693,000 | 0.04% |
| X-Square Capital, LLC | 17,973 | $36,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $537,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $910,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $95,000 | 0.00% |